Satsuma Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Satsuma Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2022.
  • Satsuma Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending March 31, 2023 was -$10.8M, a 30.7% increase year-over-year.
  • Satsuma Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending March 31, 2023 was -$66.2M, a 17.6% decline year-over-year.
  • Satsuma Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$70.9M, a 38.7% decline from 2021.
  • Satsuma Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$51.2M, a 5.87% decline from 2020.
  • Satsuma Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$48.3M, a 67.3% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$70.9M -$19.8M -38.7% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-28
2021 -$51.2M -$2.84M -5.87% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 -$48.3M -$19.4M -67.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 -$28.9M -$21.4M -284% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$7.52M -$2.57M -51.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 -$4.95M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.